<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03706846</url>
  </required_header>
  <id_info>
    <org_study_id>P/2017/343</org_study_id>
    <nct_id>NCT03706846</nct_id>
  </id_info>
  <brief_title>Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids</brief_title>
  <acronym>GASTROPREP</acronym>
  <official_title>Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Upper gastrointestinal endoscopy is the key examination for screening for precancerous and
      cancerous lesions of the esophagus and stomach. This study aims to describe the quality of
      the visualization of the esophageal and gastric mucosa, the safety of use of two fasting
      procedures before gastroscopy and the feeling of patients. The population evaluated here
      concerns cirrhotic patients, at high risk of developing a precancerous lesion of the upper
      gastrointestinal tract.

      The investigator carries out a prospective, monocentric (Besançon CHRU), interventional and
      randomized study according to two fasting procedures before gastroscopy: 6 hours (F6 group)
      versus 2 hours (F2 group) for clear fluids. The primary endpoint was to describe and compare
      the quality of visualization of the esophageal and gastric mucosa, graded from A (good
      quality) to C (poor quality) according to a score. developed by Elvas et al. (Endoscopy
      2017).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 18, 2018</start_date>
  <completion_date type="Actual">August 27, 2018</completion_date>
  <primary_completion_date type="Actual">August 27, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score for quality of visualization of the esophageal and gastric mucosa</measure>
    <time_frame>During endoscopy</time_frame>
    <description>The score is graded from A (good quality) to C (poor quality) according to a score developed by Elvas et al. (Endoscopy 2017).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaire concerning security</measure>
    <time_frame>During endoscopy</time_frame>
    <description>Questionnaire filled by the investigator concerning the side effectets observed or not observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire concerning patient confort during fasting</measure>
    <time_frame>The day of the endoscopy</time_frame>
    <description>Snsations felt or not felt by the patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Fasting 2 hours</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fasting 2 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fasting 6 hours</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fasting 6 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fasting</intervention_name>
    <description>fasting before gastrointestinal endoscopy</description>
    <arm_group_label>Fasting 2 hours</arm_group_label>
    <arm_group_label>Fasting 6 hours</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years,

          -  Male or female

          -  Cirrhosis based on radiological, clinical, biological or histological criteria

        Exclusion Criteria:

          -  Diabetes for more than 10 years;

          -  Under 18 years of age;

          -  History of inhalation

          -  Patients in whom the gastrointestinal anatomy has not been retained

          -  Subjects who were unlikely to cooperate with the study and / or in whom poor
             cooperation was anticipated by the investigator

          -  Pregnant women Patients taking drugs that may slow down gastric Emptying such as:
             anticholinergic drugs, phenothiazines, antidepressants History of esophageal
             radiotherapy Unsubstituted hypothyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2018</study_first_posted>
  <last_update_submitted>October 15, 2018</last_update_submitted>
  <last_update_submitted_qc>October 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cirrhosis</keyword>
  <keyword>Upper digestive endoscopy</keyword>
  <keyword>fasting</keyword>
  <keyword>esophageal cancer</keyword>
  <keyword>Superficial neoplastic lesions</keyword>
  <keyword>Esophageal mucosa</keyword>
  <keyword>Gastric mucosa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

